Brought to you by 
Lion Bioscience raises $209mm in IPO
31 Aug 2000
Executive Summary
In an IPO in the US and Germany of about 5.3mm shares, bioinformatics technology developer Lion Bioscience raised about $209mm (Euro321.4mm), including the underwriter's overallotment. The company sold its shares at $39.68 each, about the midpoint of its anticipated range.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lion Bioscience raises $209mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice